TRDA vs USB · P/E 12, rev $210.8M vs P/E 12, rev $28.66B
Entrada Therapeutics Inc (TRDA) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
TRDA currently screens at market cap $274.4M and trailing P/E 12.5. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the TRDA and USB stock pages for the full models.
Not investment advice.